Patients and Medical
Bringing hope in hemophilia
By collaborating, gathering compelling global data and sharing knowledge hemophilia advocates are driving fairer and broader access to diagnosis and treatment
Multichannel
How Pharma can win back its online voice
Customer engagement now starts online. Around 80% of patients Google a recommended or newly-prescribed medication. And doctors routinely...
Commercial
Paving the payment path for DTx
The case for Digital therapeutics (DTx) has never been stronger. Each month new DTx are securing approval, some are finding paying...
Latest
-
-
Patients and Medical
Clinical trials: Japan’s next chapter
Post COVID-19, keeping patients at the center of plans for clinical trial design in Japan is vital -
Multichannel
From the Great Resignation to the Great Re-Engagement
In the war for talent, an employee-centered focus on purpose, personal discovery, learning, and innovation is a winning strategy, says medical communications business Healthcare Consultancy Group (HCG) -
Multichannel
How Pharma can win back its online voice
Is your content even a tiny part of the online conversations about your disease and therapeutic areas? A look at the search results might horrify you -
Commercial
Paving the payment path for DTx
The digital therapeutics reimbursement process is maturing but complexity and risk remain to be managed
Most Popular
Mary Nishikawa, (Aug 31, 2022)
Post COVID-19, keeping patients at the center of plans for clinical trial design in Japan is vital
Jill Donahue, (Sep 5, 2022)
For Ana Paula Carvalho, President of Western Europe Cluster, Pfizer, her purpose began amidst overcoming challenges.
Andrew Stone, (Sep 9, 2022)
By collaborating, gathering compelling global data and sharing knowledge hemophilia advocates are driving fairer and broader access to diagnosis and treatment
Opinion
Jill Donahue, (Sep 5, 2022)
For Ana Paula Carvalho, President of Western Europe Cluster, Pfizer, her purpose began amidst overcoming challenges.
Jill Donahue, (Feb 13, 2022)
Paying it forward and helping others act on their patient-driven purpose is the goal of this pharma leader
Commercial
-
Becoming agile in experience measurement
The customer experience is pharma’s new competitive battleground – trust is its key metric, and the prizes will go to the nimble -
Paving the payment path for DTx
The digital therapeutics reimbursement process is maturing but complexity and risk remain to be managed -
The field force: Is small beautiful?
As big pharma ponders the right sizing of its post-pandemic field forces, can it learn from smaller, leaner industry peers about doing more with less? -
Cell & Gene Therapy: High stakes and high hopes for healthcare
Now that CGT is proving its worth, the next task for pharma is working out the best ways to commercialise it -
Unlocking the full potential of biosimilars
The future looks bright for biosimilars in an age of crisis over healthcare affordability
Access and Evidence
-
How automation is changing regulatory affairs
Post pandemic, pharma and regulators are both working to accelerate the transformative power of electronic filing -
An early peek at the FDA’s RWE ‘cookbook’
The FDA is developing guidelines that will help pharma accelerate its adoption of RWE, this is what the industry should know -
The future is bright for RWE in pharma approvals
The FDA and other regulatory bodies are increasingly willing to accept real-world evidence as part of approvals. Pharma is up to the task -
Payers and the ABCs of digital literacy
Convincing payers of the value of digital add-ons and of drug/device combinations requires pharma to demonstrate that patients and other stakeholders understand how to use them -
Decoding the patient journey with RWD
Patient real-world data contains a wealth of potentially valuable information for life sciences commercial teams, if they can filter out the noise
Patients and Medical
-
Bringing hope in hemophilia
By collaborating, gathering compelling global data and sharing knowledge hemophilia advocates are driving fairer and broader access to diagnosis and treatment -
Clinical trials: Japan’s next chapter
Post COVID-19, keeping patients at the center of plans for clinical trial design in Japan is vital -
Patient services: a digital roadmap
Leveraging the full capabilities of digital will enable pharma to transform the patient experience -
Digital patient engagement data: Are you already falling behind?
Gathering and acting on insights from digital patient engagement data is becoming a competitive differentiator, yet many in pharma are still stuck in learning mode -
Reaching Gen-Z
Young people comprise a unique demographic that pharma is not used to serving but new digital tools offer ways to understand, engage and serve them better
Latest Videos
Upcoming Events
View All EventsOctober 2022
-
Total Health USA 2022
Oct 4, 2022 - Oct 5, 2022
-
FREE WEBINAR: The journey to omnichannel in Medical Affairs
Oct 5, 2022 - Oct 5, 2022
November 2022
-
Pharma Awards Europe 2022
Nov 17, 2022 - Nov 17, 2022
December 2022
March 2023
-
Pharma USA 2023
Mar 28, 2023 - Mar 29, 2023
April 2023
-
Pharma Europe 2023
Apr 18, 2023 - Apr 20, 2023